GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 14, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7PJR | Q6P988 | Notum_ARUK3000438 | |
7PK3 | Q6P988 | Notum_ARUK3001185 | |
7PKV | Q6P988 | Notum_Inhibitor ARUK3000223 | |
2NXY | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b | |
2NXZ | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY0 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NY1 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
2NY2 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY3 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY4 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY5 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY6 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
6AL5 | Q6P5S8 | COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB | |
6AL5 | Q6P5S8 | COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB | |
6V8Z | Q6P5S8 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6V8Z | Q6P5S8 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL |
6WM3 | Q6P5S7 | Human V-ATPase in state 2 with SidK and ADP | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, V-type proton ATPase subunit D, V-type proton ATPase subunit F |
6WLW | Q6P5S7 | The Vo region of human V-ATPase in state 1 (focused refinement) | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-) |
7U4T | Q6P5S7 | Human V-ATPase in state 2 with SidK and mEAK-7 | |
6WM2 | Q6P5S7 | Human V-ATPase in state 1 with SidK and ADP | V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H, V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, k, V-type proton ATPase subunit D, V-type proton ATPase subunit F, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1 |
6WM4 | Q6P5S7 | Human V-ATPase in state 3 with SidK and ADP | V-type proton ATPase catalytic subunit A (E.C.7.1.2.2), V-type proton ATPase subunit B, brain isoform, SidK, V-type proton ATPase 116 kDa subunit a isoform 1, V-type proton ATPase subunit C 1, V-type proton ATPase subunit E 1, V-type proton ATPase subunit G 1, V-type proton ATPase subunit D, V-type proton ATPase subunit F, V-type proton ATPase subunit S1, Renin receptor, V-type proton ATPase 21 kDa proteolipid subunit, V-type proton ATPase 16 kDa proteolipid subunit, V-type proton ATPase subunit d 1, V-type proton ATPase subunit e 1, Ribonuclease kappa (E.C.3.1.-.-), V-type proton ATPase subunit H |
7UNF | Q6P5S7 | CryoEM structure of a mEAK7 bound human V-ATPase complex | |
7RTW | Q6P5F7 | Cryo-EM structure of a TTYH3 cis-dimer | |
9B8O | Q6P503 | Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3, Vo | |
9BRD | Q6P503 | Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3 | |
5WKI | Q6P4G7 | Crystal structure of PG90 TCR-CD1b-PG complex | T-cell surface glycoprotein CD1b, Beta-2-microglobulin, T-cell receptor alpha variable 26-1,TRA@ protein, PG90 TCR beta chain |
6EA4 | Q6P179 | ERAP2 bound to Aryl Sulfonamide Uncompetitive Inhibitor | |
3SE6 | Q6P179 | Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 | Endoplasmic reticulum aminopeptidase 2 (E.C.3.4.11.-) |
4E36 | Q6P179 | Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 variant N392K | |
4JBS | Q6P179 | Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 in complex with PHOSPHINIC PSEUDOTRIPEPTIDE inhibitor. | |
5AB0 | Q6P179 | Crystal structure of aminopeptidase ERAP2 with ligand | |
5AB2 | Q6P179 | Crystal structure of aminopeptidase ERAP2 with ligand | |
5CU5 | Q6P179 | Crystal structure of ERAP2 without catalytic Zn(II) atom | |
5J6S | Q6P179 | Crystal structure of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) in complex with a hydroxamic derivative ligand | |
5K1V | Q6P179 | Crystal structure of Endoplasmic Reticulum aminopeptidase 2 (ERAP2) in complex with a diaminobenzoic acid derivative ligand. | |
7P7P | Q6P179 | Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide((1R)-1-Amino-3-phenylpropyl){(2S)-3-[((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino]-2-{[3-(2-hydroxyphenyl)-isoxazol-5-yl]methyl}-3-oxopropyl}phosphinic acid | |
7PFS | Q6P179 | Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide ((1R)-1-Amino-3-phenylpropyl){2-([1,1:3,1-terphenyl]-5-ylmethyl)-3-[((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)-amino]-3-oxopropyl}phosphinic acid | |
7NSK | Q6P179 | Endoplasmic reticulum aminopeptidase 2 complexed with a hydroxamic ligand | |
7NUP | Q6P179 | Endoplasmic reticulum aminopeptidase 2 complexed with a mixed hydroxamic and sulfonyl ligand | |
5WZY | Q6NYR1 | Crystal structure of the P2X4 receptor from zebrafish in the presence of CTP at 2.8 Angstroms | p2X purinoceptor |
3H9V | Q6NYR1 | Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 3.1 Angstroms | |
3I5D | Q6NYR1 | Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 3.5 Angstroms (R3) | |
4DW0 | Q6NYR1 | Crystal structure of the ATP-gated P2X4 ion channel in the closed, apo state at 2.9 Angstroms | P2X purinoceptor |
4DW1 | Q6NYR1 | Crystal structure of the ATP-gated P2X4 ion channel in the ATP-bound, open state at 2.8 Angstroms | P2X purinoceptor |
8JV5 | Q6NYR1 | Cryo-EM structure of the zebrafish P2X4 receptor in complex with BX430 | |
8JV6 | Q6NYR1 | Cryo-EM structure of the zebrafish P2X4 receptor in complex with BAY-1797 | |
7NDG | Q6NW40 | Cryo-EM structure of the ternary complex between Netrin-1, Neogenin and Repulsive Guidance Molecule B | Netrin-1, Neogenin, Repulsive Guidance Molecule B |
7NE0 | Q6NW40 | Structure of the ternary complex between Netrin-1, Repulsive-Guidance Molecule-B (RGMB) and Neogenin | |
7NE0 | Q6NW40 | Structure of the ternary complex between Netrin-1, Repulsive-Guidance Molecule-B (RGMB) and Neogenin | |
6Z3J | Q6NW40 | Repulsive Guidance Molecule B (RGMB) in complex with Growth Differentiation Factor 5 (GDF5) (crystal form 1) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024